Element Biosciences Secures Over $277M in Series D Funding
- Jul 17, 2024
- 1 min read
Updated: Jul 18, 2024
San Diego, CA, July 11, 2024 (PRNewswire) -- Element Biosciences has raised over $277 million in Series D funding, bringing its total funding to over $680 million. The round was led by Wellington Management and included investors like Samsung Electronics and Fidelity. This funding will support the company's advancements in DNA sequencing and multi-omics technologies.
Read full article here.
Comments